Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Published in: Clinical Rheumatology 3/2024

26-01-2024 | Correction

Correction to: Association between urate-lowering therapy and cardiovascular events in patients with asymptomatic hyperuricemia

Authors: Hiroyuki Hashimoto, Masato Takeuchi, Koji Kawakami

Published in: Clinical Rheumatology | Issue 3/2024

Login to get access

Excerpt

Correction to: Clinical Rheumatology (2023) 42:3075-3082 …
Metadata
Title
Correction to: Association between urate-lowering therapy and cardiovascular events in patients with asymptomatic hyperuricemia
Authors
Hiroyuki Hashimoto
Masato Takeuchi
Koji Kawakami
Publication date
26-01-2024
Publisher
Springer International Publishing
Published in
Clinical Rheumatology / Issue 3/2024
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-024-06866-y

Other articles of this Issue 3/2024

Clinical Rheumatology 3/2024 Go to the issue

ORIGINAL ARTICLE

Clinico-serological associations of urinary activated leukocyte cell adhesion molecule in systemic lupus erythematosus and lupus nephritis

Original Article

Study on the expression changes of lncRNA in patients with systemic lupus erythematosus and its correlation with Treg cells

REVIEW ARTICLE

Autoimmune thyroid disease and rheumatoid arthritis: where the twain meet

ORIGINAL ARTICLE

The effect of COVID-19 infection on patients with rheumatic diseases in China

Original Article

Associated factors with liver fibrosis in rheumatoid arthritis patients treated with methotrexate

ORIGINAL ARTICLE

Comparative analysis of optical coherence tomography angiography (OCTA) results between Behçet’s disease patients and a healthy control group
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits